Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells

被引:78
作者
Chung, YM
Park, SH
Park, JK
Kim, YT
Kang, YK
Yoo, YD
机构
[1] Korea Canc Ctr Hosp, Lab Expt Therapeut, Seoul 139706, South Korea
[2] Sogang Univ, Dept Life Sci, Seoul 100611, South Korea
关键词
5-fluorouracil; multidrug resistance; 5-fluorouracil-anabolizing enzymes; cross-resistance;
D O I
10.1016/S0304-3835(00)00535-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two 5-fluorouracil (5-FU)-resistant cell lines from a Korean gastric cancer cell line were established by incubation of the cells with increasing concentration of 5-FU. and the resultant cell lines showed an over 800-fold increased resistance to 5-FU. To identify the mechanism of 5-FU resistance, the expressions of genes involved in 5-FU metabolism were examined by reverse transcriptase-polymerase chain reaction (RT-PCR). Expressions of orotate phosphoribosyltransferase (OPRT), thymidine phosphorylase (TP), and uridine phosphorylase (UP) were significantly downregulated in these cell lines, resulting in low incorporation of 5-FU into nucleic acids. In contrast, an increased expression of thymidine kinase (TK) was observed in 5-FU resistant cells. These results strongly indicate that blocking of 5-FU incorporation into nucleic acids and TK overexpression may play a major role in 5-FU resistance in these cells. Interestingly, these cell lines showed cross-resistance to paclitaxel, cisplatin, and doxorubicin. suggesting that other factors such as HSP27 and Mn-SOD could be also involved in the mechanism of multidrug resistance in these cell lines. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 19 条
[1]   A ROLE FOR DIHYDROPYRIMIDINE DEHYDROGENASE AND THYMIDYLATE SYNTHASE IN TUMOR SENSITIVITY TO FLUOROURACIL [J].
BECK, A ;
ETIENNE, MC ;
CHERADAME, S ;
FISCHEL, JL ;
FORMENTO, P ;
RENEE, N ;
MILANO, G .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (10) :1517-1522
[2]  
CIOCCA DR, 1992, CANCER RES, V52, P3648
[3]   THYMIDYLATE SYNTHASE GENE AMPLIFICATION IN HUMAN COLON-CANCER CELL-LINES RESISTANT TO 5-FLUOROURACIL [J].
COPUR, S ;
AIBA, K ;
DRAKE, JC ;
ALLEGRA, CJ ;
CHU, E .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (10) :1419-1426
[4]   RESPONSE TO FLUOROURACIL THERAPY IN CANCER-PATIENTS - THE ROLE OF TUMORAL DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY [J].
ETIENNE, MC ;
CHERADAME, S ;
FISCHEL, JL ;
FORMENTO, P ;
DASSONVILLE, O ;
RENEE, N ;
SCHNEIDER, M ;
THYSS, A ;
DEMARD, F ;
MILANO, G .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) :1663-1670
[5]  
Fischel JL, 1995, CLIN CANCER RES, V1, P991
[6]  
HUOT J, 1991, CANCER RES, V51, P5245
[7]   Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells [J].
Inaba, M ;
Mitsuhashi, J ;
Sawada, H ;
Miike, N ;
Naoe, Y ;
Daimon, A ;
Koizumi, K ;
Tsujimoto, H ;
Fukushima, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (02) :212-220
[8]  
Ishikawa Y, 1999, CLIN CANCER RES, V5, P883
[9]   Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival [J].
Lenz, HJ ;
Leichman, CG ;
Danenberg, KD ;
Danenberg, PV ;
Groshen, S ;
Cohen, H ;
Laine, L ;
Crookes, P ;
Silberman, H ;
Baranda, J ;
Garcia, Y ;
Li, J ;
Leichman, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :176-182
[10]  
Look KY, 1997, ANTICANCER RES, V17, P2353